Recruitment

Recruitment Status
Terminated

Exclusion Criteria

life expectancy < 6 months
prior history of ipsilateral DVT or femoral catheters
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
...
life expectancy < 6 months
prior history of ipsilateral DVT or femoral catheters
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
pregnancy
severe kidney disease (creatinine clearance < 30 mL min)
the lesion cannot be accessed with the wire guide
allergy to contrast media
refusal to provide informed consent or inability to follow up

Summary

Conditions
  • Deep Vein Thrombosis
  • Venous Thromboembolism
Type
Interventional
Phase
Phase 2
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Exclusion Criteria

life expectancy < 6 months
prior history of ipsilateral DVT or femoral catheters
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
...
life expectancy < 6 months
prior history of ipsilateral DVT or femoral catheters
indications for thrombolytic therapy (i.e. phlegmasia cerulean dolens)
pregnancy
severe kidney disease (creatinine clearance < 30 mL min)
the lesion cannot be accessed with the wire guide
allergy to contrast media
refusal to provide informed consent or inability to follow up

Tracking Information

NCT #
NCT02066597
Collaborators
Not Provided
Investigators
  • Principal Investigator: Esteban Gandara, MD OHRI
  • Esteban Gandara, MD OHRI